SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4,661.82 |
| Enterprise Value ($M) | 4,516.13 |
| Book Value ($M) | 1,069.79 |
| Book Value / Share | 16.17 |
| Price / Book | 4.36 |
| NCAV ($M) | 1,060.49 |
| NCAV / Share | 16.03 |
| Price / NCAV | 4.40 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.24 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | -0.39 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 20.96 |
| Current Ratio | 20.96 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,132.45 |
| Assets | 1,141.75 |
| Liabilities | 71.96 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -280.37 |
| Net Income | -260.76 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -185.06 |
| Cash from Investing | -573.51 |
| Cash from Financing | 568.88 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Flynn James E | 27.59 | -7.81 | |
| 13G/A | Vanguard Group Inc | 6.85 | 34.73 | |
| 13G/A | Paradigm Biocapital Advisors LP | 7.80 | 29.60 | |
| 13G/A | Perceptive Advisors Llc | 4.60 | 2.10 | |
| 13G | BlackRock, Inc. | 5.60 | 0.00 | |
| 13D/A | Bain Capital Life Sciences Fund II, L.P. | 4.10 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 121,010 | 412,092 | 29.36 | |
| 148,743 | 413,376 | 35.98 | |
| 336,891 | 910,281 | 37.01 | |
| 250,537 | 765,681 | 32.72 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NEOG – Neogen Corporation | NKTX – Nkarta, Inc. |
| NMRA – Neumora Therapeutics, Inc. | NVAX – Novavax, Inc. |
| NXTC – NextCure, Inc. |
Financial data and stock pages provided by
Fintel.io